THINKING ABOUT THE START OF THE
NEXT WORKWEEK, OVER TO YOU.
THANK YOU, RICH.
HIS DEATH SHOCKED AND
SURPRISED FANS AROUND THE WORLD.
LEGENDARY ROCKER DAVID BOWIE
PASSED AWAY SUNDAY AFTER AN
18-MONTH BATTLE WITH CANCER, HIS
FAMILY HASN'T CONFIRMED WHAT
KIND OF CANCER BOWIE HAD,
ACCORDING TO A CLOSE FRIEND HE
SUFFER FRDZ LIVE CANCER.
AND REPORTS THE 69-YEAR-OLD
FOUGHT BACK SIX HEART ATTACKS IN
THE PAST YEAR.
HE DID MANAGE TO RELEASE HIS
FINAL ALBUM "BLACK STAR"
RELEASED FRIDAY ON HIS BIRTHDAY.
EITHER WAY BOTH ARE TOUGH
OBATTLE.
LIVER CANCER, ALL WE NO IS
LIVER CANCER.
AS YOU SAID IS THIS SOMETHING
THAT SPREAD THE LUNG OR
SOMEWHERE ELSE.
THE MOST COMMON TUMOR OF THE
LIVER IS CANS THEY ARE SPREAD
THERE FROM SOME OTHER PART OF
THE BODY.
AND SO, THE SPECULATION IS THAT
DAVID BOWIE WAS MALE, INCIDENTS
OF LUNG CANCER.
Bruce: AND HE SMOKED.
IT COULD BE LUNG CANS THEY
ARE SPREAD TO HIS LIVER, OR
PRIMARY LIVER CANCER HELP LESS
FREQUENTLY BUT ALSO THEY'RE
INCREASING IN PREVALENCE.
SCA.
EITHER CASE THE SURVIVAL
RATE IS VERY SMALL, SOMETHING
LIKE 17%.
A PATIENT WITH LUNG CANCER
OR SOME OTHER CANCER, COLON
CANCER THAT SPREADS TO THE
LIVER, USUALLY THOSE PATIENTS
HAVE A VERY, VERY LOW SURVIVAL
RATE.
HELPAT -- HEPPATO CELLULAR CARS
NOME ARE ARE CAUGHT WHEN IT IS
TOO LARGE TO REMOVE SURGICALLY
AND TOO LATE BECAUSE WHEN THEY
GROW AND THEY'RE VERY SMALL
THERE IS NO SYMPTOMS.
WE DON'T KNOW THEY'RE EVEN
THERE.
THE ONES THAT ARE CURED ARE ONES
THAT ARE FOUND SAIRN DEPUTIOUSLY
WHEN A PATIENT HAS A CAT SCAN
FOR SOME OTHER REASON.
HE HADN'T BEEN SEEN IN
PUBLIC EXCEPT ONE OR TWO RARE
OXES IN 18 MONTHS AND THE
SPECULATION WAS HE WAS TOO ILL
BASICALLY TO OGO OUT.
AND AS WE TALK ABOUT THIS I WANT
TO SHOW YOU HIS LAST VIDEO.
IT IS CLEAR THAT HE WAS SENDING
A MESSAGE TO HIS FANS WITH THIS
MUSIC VIDEO.
HE'S LYING THERE IN THE HOSPITAL
BED, YOU CAN SEE THAT HE'S
BANDAGED.
IT IS HIS WAY OF SAYING, THAT I
FOUGHT THIS BATTLE AND I'M
TELLING YOU GOOD-BYE.
HE DIDN'T GO PUBLIC WITH IT.
BUT ARE BOTH OF THESE CANCERRING
LINGERING.
LIVER CANCER OR LUNG CANCER
A THAT SPHREEDZ THE LIVER THIS
PATIENT, THE 18 MONTHS IS A
LITTLE BIT LONG.
IT IS WITHIN THE NORMAL RANGE,
MOST PATIENTS SUCCUMB TO THAT
CANSER IN 6 TO 12 MONTHS, MAIN
14 MONTH.
18 MONTHS IS A LITTLE LONG BUT
NOT OUTSIDE THE REALM OF
POSSIBILITIES.
AND IF IT WAS A TUMOR THAT BEGAN
IN THE LIVER THOSE PATIENTS AS
WELL, ABOUT THE LONG END OF THE
SURVIVAL.
WHAT WOULD THEY HAVE DONE
THE TRY TO MITIGATE THE CANCER
THE TRADITIONAL THERAPIES IN.
IF THE CANCER CAUGHT EARLY
IN THE LIVER AND NO OTHER SIGN
OF CANCER ELSEWHERE IN THE BODY,
YOU CAN REMOVE IT SURGICALLY,
YOU CAN PROVIDE RADIATION
TREATMENTS TO IT WIRKS WE DO.
OR PATIENTS RECEIVE CHEMOTHERAPY
SO WE COULD BE RECEIVING
CHEMOTHERAPY AND THAT WOULD HAVE
HELPED HIM TO LIVE A LONGER
TIME.
THERE HAS BEEN -- IF IT WAS A
PRIMARY LIVER CANCER, NEW DRUGS
APPROVED BY THE FDA THAT WOULD
BE USED IN CLINICAL TRIALS AND
FAIRLY EFFECTIVE FOR THEM.
NOT REALLY CURING THEM, BUT
INCREASING THE SURVIVAL REQUEST
WHAT IS THE QUALITY OF LIFE OF
THOSE DRUG?
IT IS NOT TOO BAD.
IT IS MORE TARGETED THERAPIES AS
WE'VE TALKED ABOUT BEFORE
BECAUSE THEY'RE TARGETING THE
CANCER AND YES IN THETIC
MALFORMATION AND THEY HAVE LOT
DIFFERENT SIDE EFFECTS IT IS
STILL DRAIN TONGUE BODY AND
SUPPRESSES THEIR IMMUNE SYSTEM,
THEY'RE MORE SUBJECT TO GETTING
PNEUMONIA.
THERE IS STILL A BATTLE.
STILL A BAT.
BUT NOT AS DEVASTATING
TREATMENTS THESE DAYS ARE NOT AS
DEVASTATING AS SYSTEMIC
TREATMENTS IN THE PAST.
Bruce: THANK YOU VERY MUCH.